The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Danley, D.
Right arrow Articles by Bokoch, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Danley, D.
Right arrow Articles by Bokoch, G.

The Journal of Immunology, Vol 157, Issue 2 500-503, Copyright © 1996 by American Association of Immunologists


CUTTING EDGE

Defective Rho GTPase regulation by IL-1 beta-converting enzyme-mediated cleavage of D4 GDP dissociation inhibitor

DE Danley, TH Chuang and GM Bokoch
Department of Molecular Sciences, Pfizer Central Research, Groton, CT 06340, USA.

GTPases of the Rho family regulate many aspects of inflammatory cell activity, including motility, formation of toxic oxygen metabolites, and generation of proinflammatory cytokines. Defective regulation of such signaling pathways leads to a variety of acute and chronic inflammatory disorders, although the mechanisms by which this occurs have not been well defined. We describe in this work specific proteolytic cleavage of D4 GDI, a critical regulator of Rho GTPase activity in inflammatory leukocytes, by IL-1 beta-converting enzyme (ICE). Cleavage of D4 GDI by ICE occurs at Asp55, leading to the formation of the truncated D4 that is unable to effectively bind and regulate GTPases of the Rho family. Our data suggest that activation of ICE protease(s) at inflammatory sites leads to defective Rho GTPase regulation. Release of these critical regulatory proteins may contribute substantially to the inflammatory response at these sites, exacerbating and perpetuating the resulting tissue damage.


This article has been cited by other articles:


Home page
Int ImmunolHome page
K. Kondoh, Y. Nakata, T. Yamaoka, M. Itakura, M. Hayashi, K. Yamada, J.-i. Hata, and T. Yamada
Altered cellular immunity in transgenic mice with T cell-specific expression of human D4-guanine diphosphate-dissociation inhibitor (D4-GDI)
Int. Immunol., October 1, 2008; 20(10): 1299 - 1311.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
D. Rosel, J. Brabek, O. Tolde, C. T. Mierke, D. P. Zitterbart, C. Raupach, K. Bicanova, P. Kollmannsberger, D. Pankova, P. Vesely, et al.
Up-Regulation of Rho/ROCK Signaling in Sarcoma Cells Drives Invasion and Increased Generation of Protrusive Forces
Mol. Cancer Res., September 1, 2008; 6(9): 1410 - 1420.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
R. Kettritz, Y.-X. Xu, B. Faass, J. B. Klein, E.-C. Müller, A. Otto, A. Busjahn, F. C. Luft, and H. Haller
TNF-{alpha}-mediated neutrophil apoptosis involves Ly-GDI, a Rho GTPase regulator
J. Leukoc. Biol., August 1, 2000; 68(2): 277 - 283.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
A. Roulston, C. Reinhard, P. Amiri, and L. T. Williams
Early Activation of c-Jun N-terminal Kinase and p38 Kinase Regulate Cell Survival in Response to Tumor Necrosis Factor alpha
J. Biol. Chem., April 24, 1998; 273(17): 10232 - 10239.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.